Time to Surgery in Early-Stage Non-Small Cell Lung Cancer: An Interview With Jeffrey Velotta

CTSNet Editor-in-Chief Dr. Joel Dunning recently had the opportunity to speak with Dr. Jeffrey Velotta, thoracic surgeon at Kaiser Permanente Oakland Medical Center, regarding his paper, Time to Surgery in Early-Stage Non-Small Cell Lung Cancer: Defining the Optimal Diagnosis-to-Resection Interval to Reduce Mortality. 

Their discussion covered the key takeaway messages from the study and the factors contributing to delays in surgery. They also explored nodal staging, including the current recommendations and guidelines, as well as tissue diagnosis. Furthermore, Dr. Velotta shared insights into why he chose to research this pressing issue, along with an overview of the study’s objectives and findings. Additionally, they delved into neoadjuvant and adjuvant therapy in the treatment of early-stage non-small cell lung cancer.  

Related Resources 

1. Time to Surgery in Early-Stage Non-Small Cell Lung Cancer: Defining the Optimal Diagnosis-to-Resection Interval to Reduce Mortality  

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.